Verona Pharma plc buy Cantor Fitzgerald
Start price
21.04.25
/
50%
€0.51
Target price
21.04.26
€69.71
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 21.04.26. The prediction end date can be changed by Cantor_Fitzgerald at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Verona Pharma plc | - | - |
| iShares Core DAX® | 0.754% | -1.027% |
| iShares Nasdaq 100 | -2.859% | -4.266% |
| iShares Nikkei 225® | 4.946% | 5.736% |
| iShares S&P 500 | -1.254% | -2.357% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma plc (NASDAQ: VRNA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $80.00 price target on the stock.
Ratings data for VRNA provided by MarketBeat